Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary

Add time:07/14/2019    Source:sciencedirect.com

BackgroundWAG/Rij rats represent a validated genetic animal model of epileptogenesis, absence epilepsy and depressive-like comorbidity. Some treatments (e.g. ethosuximide), using specific protocols, prevent the development of spontaneous absence seizures. Accordingly, ethosuximide increases remission occurrence in children with childhood absence epilepsy in comparison to valproic acid. Considering that in this animal model, antiepileptogenic effects are, in some cases, not retained over time, we studied whether the antiepileptogenic effects of both ethosuximide and levetiracetam (which also possesses antiepileptogenic effects in this and other animal epilepsy models) would be retained 5 months after drug suspension.

We also recommend Trading Suppliers and Manufacturers of Levetiracetam acid (cas 103833-72-3). Pls Click Website Link as below: cas 103833-72-3 suppliers

Prev:Nose-to-brain delivery of levetiracetam after intranasal administration to mice
Next:Theoretical studies on racemization of levetiracetam: Structural movements, character of hydroxide ion and guidelines for efficient control)